Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Shepherd

Showing results (651-660 of 726) with videos related to

Pageof 73
Sort By:
Clinical Breast Cancer|November 13, 2017
Vitamin D Levels, Vitamin D Receptor Polymorphisms, and Inflammatory Cytokines in Aromatase Inhibitor-Induced Arthralgias: An Analysis of CCTG MA.27Polly Niravath, Bingshu Chen, Judy-Anne W Chapman, et al.
Nature Communications|June 22, 2026
Generating synthetic multi-national longitudinal cohorts for clinically grounded HIV researchZhuohui J Liang, Zhuohang Li, Nicholas J Jackson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2016
Higher Time-Updated Body Mass Index: Association With Improved CD4+ Cell Recovery on HIV TreatmentJohn R Koethe, Cathy A Jenkins, Bryan Lau, et al.
British Journal of Haematology|May 27, 2024
Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre-autologous stem cell transplant in relapsed/refractory diffuse large B-cell lymphoma-outcome of rituximab-dose-intensive cyclophosphamide, etoposide, cisplatin (R-DICEP) versus R-GDPDouglas A Stewart, John Kuruvilla, David Lee, et al.
Pharmacogenetics and Genomics|June 19, 2019
Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancerJames N Ingle, Krishna R Kalari, Yukihide Momozawa, et al.
The New England Journal of Medicine|February 28, 2024
Simple versus Radical Hysterectomy in Women with Low-Risk Cervical CancerMarie Plante, Janice S Kwon, Sarah Ferguson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2017
Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trialsR Yerushalmi, B Dong, J W Chapman, et al.
British Journal of Haematology|January 20, 2007
A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7Chaim Shustik, Andrew Belch, Sue Robinson, et al.
Breast Cancer Research and Treatment|January 2, 2015
Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trialShuzhen Liu, Judy-Anne W Chapman, Margot J Burnell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2011
Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14Kathleen I Pritchard, Lois E Shepherd, Judith-Anne W Chapman, et al.
Pageof 73

Showing results (651-660 of 726) with videos related to

Sort By:
Pageof 73
Clinical Breast Cancer|November 13, 2017
Vitamin D Levels, Vitamin D Receptor Polymorphisms, and Inflammatory Cytokines in Aromatase Inhibitor-Induced Arthralgias: An Analysis of CCTG MA.27Polly Niravath, Bingshu Chen, Judy-Anne W Chapman, et al.
Nature Communications|June 22, 2026
Generating synthetic multi-national longitudinal cohorts for clinically grounded HIV researchZhuohui J Liang, Zhuohang Li, Nicholas J Jackson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2016
Higher Time-Updated Body Mass Index: Association With Improved CD4+ Cell Recovery on HIV TreatmentJohn R Koethe, Cathy A Jenkins, Bryan Lau, et al.
British Journal of Haematology|May 27, 2024
Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre-autologous stem cell transplant in relapsed/refractory diffuse large B-cell lymphoma-outcome of rituximab-dose-intensive cyclophosphamide, etoposide, cisplatin (R-DICEP) versus R-GDPDouglas A Stewart, John Kuruvilla, David Lee, et al.
Pharmacogenetics and Genomics|June 19, 2019
Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancerJames N Ingle, Krishna R Kalari, Yukihide Momozawa, et al.
The New England Journal of Medicine|February 28, 2024
Simple versus Radical Hysterectomy in Women with Low-Risk Cervical CancerMarie Plante, Janice S Kwon, Sarah Ferguson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2017
Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trialsR Yerushalmi, B Dong, J W Chapman, et al.
British Journal of Haematology|January 20, 2007
A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7Chaim Shustik, Andrew Belch, Sue Robinson, et al.
Breast Cancer Research and Treatment|January 2, 2015
Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trialShuzhen Liu, Judy-Anne W Chapman, Margot J Burnell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2011
Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14Kathleen I Pritchard, Lois E Shepherd, Judith-Anne W Chapman, et al.
Pageof 73